Megan Nolan on GLP-1s: the quiet transformation of body, desire, and self
By
Megan Nolan
Summary
Novelist Megan Nolan explores the cultural and personal dimensions of GLP-1 weight-loss drugs through a close-up portrait of a friend's experience. The article examines how these medications flatten desire, reshape identity, and alter social rituals around food and the body, weaving personal observation with broader reflections on health, selfhood, and control in an era of pharmaceutical body transformation.
Source
Twitter / XMegan Nolan on GLP-1s: the quiet transformation of body, desire, and selfft.trib.alKey quotes
· 3 pulledIn the general flattening of her desires, some days she gets to bedtime and realises she has barely drunk a single cup all day.
She has been on a GLP-1 for four months and lost 40 pounds (18kg), but nobody knows.
Water, she says, is the unexpected thing she now has to remind herself to ingest.
You might also wanna read
Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows
This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p
theverge.com·1mo ago
Study: GLP-1 Weight Loss Drugs Linked to Decline in Daily Physical Activity
A new study analyzing NIH All of Us Research Program data, including Fitbit activity records and electronic health records, reveals that adu
neurosciencenews.com·24d ago
GLP-1 Drugs Linked to 30% Lower Breast Cancer Risk in New Study
New research published in the Journal of Clinical Oncology suggests GLP-1 weight loss medications may reduce cancer risk. An observational s
forbes.com·25d ago
Satirical Examination of GLP-1 Weight-Loss Medication Myths and Facts
The article is a satirical piece from The Onion that humorously examines myths and facts about GLP-1 weight-loss medications. It presents ab
The Onion·2mo ago
GLP-1 Medications Show Promise for Treating Addiction Through Brain Reward Pathways
The article explores the emerging potential of GLP-1 medications like Ozempic to treat various addictions beyond their original diabetes and
newyorker.com·4mo ago
Study: Most Patients Regain Weight and Lose Health Benefits After Stopping GLP-1 Drugs
A study on tirzepatide (a GLP-1 drug) found that after stopping the medication, 82% of participants regained at least 25% of the weight they
arstechnica.com·7mo ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.